OBJECTIVE: To determine the relationship between the Arg72Pro polymorphism of p53 and the outcome after traumatic brain injury (TBI) in humans. DESIGN AND SETTING: A prospective study was carried out in a ten-bed surgical intensive care unit (SICU) of a university hospital. PATIENTS: The study included 90 caucasian patients who had experienced a severe TBI within the previous 24 h. The exclusion criterion was a previous deficit in the central nervous system. MEASUREMENTS AND RESULTS: The main recorded outcomes were values on the Glasgow Outcome Scale (GOS) at discharge from the SICU (GOS-0) and 6 months later (GOS-6). A blood sample was taken from each patient and all samples were analyzed by an allele-specific polymerase chain reaction for detection of Arg72Pro polymorphism of p53. These polymorphisms were tested for their association with values of GOS-0 and GOS-6. A two-tailed value of p<0.05 was considered statistically significant. The frequency of the argine/argine (Arg/Arg) genotype was greater among the patients who had a bad outcome at GOS-0 (69 vs 31% in the bad-outcome group; p=0.029). A multiple logistic regression analysis showed that patients with the Arg/Arg variation had a 2.9-fold greater risk of having a bad outcome at discharge from the SICU (95% confidence interval, 1.05-8.31; p=0.039 ). There was no similar relationship with respect to GOS-6. CONCLUSION: The Arg/Arg genotype of the Arg72Pro polymorphism in p53 is associated with increased likelihood of a bad outcome at discharge from the SICU.
OBJECTIVE: To determine the relationship between the Arg72Pro polymorphism of p53 and the outcome after traumatic brain injury (TBI) in humans. DESIGN AND SETTING: A prospective study was carried out in a ten-bed surgical intensive care unit (SICU) of a university hospital. PATIENTS: The study included 90 caucasian patients who had experienced a severe TBI within the previous 24 h. The exclusion criterion was a previous deficit in the central nervous system. MEASUREMENTS AND RESULTS: The main recorded outcomes were values on the Glasgow Outcome Scale (GOS) at discharge from the SICU (GOS-0) and 6 months later (GOS-6). A blood sample was taken from each patient and all samples were analyzed by an allele-specific polymerase chain reaction for detection of Arg72Pro polymorphism of p53. These polymorphisms were tested for their association with values of GOS-0 and GOS-6. A two-tailed value of p<0.05 was considered statistically significant. The frequency of the argine/argine (Arg/Arg) genotype was greater among the patients who had a bad outcome at GOS-0 (69 vs 31% in the bad-outcome group; p=0.029). A multiple logistic regression analysis showed that patients with the Arg/Arg variation had a 2.9-fold greater risk of having a bad outcome at discharge from the SICU (95% confidence interval, 1.05-8.31; p=0.039 ). There was no similar relationship with respect to GOS-6. CONCLUSION: The Arg/Arg genotype of the Arg72Pro polymorphism in p53 is associated with increased likelihood of a bad outcome at discharge from the SICU.
Authors: R Bullock; R M Chesnut; G Clifton; J Ghajar; D W Marion; R K Narayan; D W Newell; L H Pitts; M J Rosner; J W Wilberger Journal: Eur J Emerg Med Date: 1996-06 Impact factor: 2.799
Authors: A Storey; M Thomas; A Kalita; C Harwood; D Gardiol; F Mantovani; J Breuer; I M Leigh; G Matlashewski; L Banks Journal: Nature Date: 1998-05-21 Impact factor: 49.962
Authors: R S Morrison; H J Wenzel; Y Kinoshita; C A Robbins; L A Donehower; P A Schwartzkroin Journal: J Neurosci Date: 1996-02-15 Impact factor: 6.167
Authors: D H Smith; X H Chen; J E Pierce; J A Wolf; J Q Trojanowski; D I Graham; T K McIntosh Journal: J Neurotrauma Date: 1997-10 Impact factor: 5.269
Authors: Narendra Nathoo; Pradeep K Narotam; Devendra K Agrawal; Catherine A Connolly; James R van Dellen; Gene H Barnett; Runjan Chetty Journal: J Neurosurg Date: 2004-08 Impact factor: 5.115
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker Journal: Intensive Care Med Date: 2006-02-17 Impact factor: 17.440
Authors: A Costanza; K Weber; S Gandy; C Bouras; P R Hof; P Giannakopoulos; A Canuto Journal: Neuropathol Appl Neurobiol Date: 2011-10 Impact factor: 8.090
Authors: Claudia S Robertson; Shankar P Gopinath; Alex B Valadka; Mai Van; Paul R Swank; J Clay Goodman Journal: J Neurotrauma Date: 2011-05-04 Impact factor: 5.269
Authors: Kaleigh Mellett; Dianxu Ren; Sheila Alexander; Nicole Osier; Sue R Beers; David O Okonkwo; Ava M Puccio; Yvette P Conley Journal: Biol Res Nurs Date: 2020-03-24 Impact factor: 2.522